Introduction
would include the full-length viral genome RNA and subgenomic RNAs. The subgenomic RNAs would all be The conventional approach to achieve high level expres-3Ј co-terminal but with different 5Ј ends, each produced sion of a foreign gene in plants involves transformation from RNA promoters located internally in the viral genome of a plant with the gene of interest coupled to a suitable ( Figure 1 ). The synthesis of subgenomic RNAs is a viral promoter. Although this strategy has been successful there strategy to permit translation of ORFs located downstream is often variable expression of the transgene in different of ORF1 (Figure 1, step 6) . Steps 3 to 6 of the scheme plant lines produced with the same construct (Hobbs et al., described in Figure 1 represent the normal RNA-based 1990; Peach and Velten, 1991; Longstaff et al., 1993) .
replication cycle of PVX.
Step 5 in the scheme represents Consequently, to analyse the phenotype of a transgene it an RNA amplification step in the replication cycle of the may be necessary to generate many transgenic lines, either virus so that, if a foreign gene is inserted into the PVX to average out the noise in the experimental data, or to amplicon as part of a subgenomic RNA, it would be identify a rare line in which the transgene is stably expressed at much higher levels than if expressed directly expressed at the required high level.
from a transgene promoter. Moreover, since the contribuMuch of the variation in transgene expression is probtion of viral replication to the steady state level of the ably due to chromosomal effects. For example, the transtransgene-derived RNA would mask the variation in direct gene could have integrated in a domain lacking features transcription we predicted that foreign gene expression of the DNA or chromatin that are necessary for high level expression. These features could facilitate transcription or would be reproducibly high in every plant. genes (encoding proteins of 25, 12 and 8 kDa respectively); CP, coat protein gene. The GUS sequence, shown as a hatched box, was inserted as an additional ORF in PVX/GUS/CP and was expressed from a duplicated CP subgenomic promoter, or as a direct replacement for the CP in PVX/GUS. PVX/ΔREP/CP was essentially PVX/GUS but with a 1.7 kb deletion within the RdRp ORF to prevent the initiation of viral replication.
of the transgene in the amplicon plants initiated the PVX replication cycle and resulted in the accumulation of GUS, as predicted. However, the expression of the amplicon constructs did not result in consistently high levels of GUS activity. In fact, rather than achieving high-level transgene expression, the amplicons produced a high level of post-transcriptional gene silencing in every plant of every line tested. Step 3, the first ORF is translated to produce the PVX RNA-dependent RNA polymerase (RdRp), which is required with host a replacement for the coat protein (PVX/GUS; Figure 2 ).
factors for PVX replication;
Step 4, the RdRp initiates synthesis of a Control plants were also generated which expressed a negative strand RNA at the 3Ј end of the transgene-derived RNA.
defective PVX/GUS construct encoding a non-functional
Using the transgene-derived RNA as a template the RdRp synthesizes RNA-dependent RNA polymerase (PVX/ΔREP/GUS; a full-length negative strand RNA;
Step 5, using the negative strand To simplify subsequent analyses we selected lines in negative strand to produce subgenomic RNAs. This stage in the replication cycle represents an RNA amplification step.
Step 6, the which there was a single transgene insert. These plant first ORF on each of the subgenomic RNAs is translated to produce lines (five to seven independent lines for each construct)
GUS and the viral proteins required for movement.
were identified by DNA gel blot analysis of the primary transformants (T 0 plants) and by the segregation ratios for Here we describe constructs in which a foreign gene GUS and/or the nptII gene in the T 0 selfed progeny (T 1 [the β-glucuronidase (GUS) reporter gene] was inserted plants) (data not shown). into the PVX amplicon so that expression of GUS would be dependent on initiation of the viral replication cycle in Expression of the PVX transgenes the transgenic plants and production of the viral subSurprisingly, none of the amplicon plants exhibited symptoms of PVX infection. However, as expected, there were genomic mRNAs. We demonstrate here that expression virus particles in the amplicon plants expressing the PVX transgene and in many tissue types of these plants including true leaves, stems, cotyledons and roots (Figure 3 ). or PVX/GUS/CP transgene. It could be ruled out that the lack of PVX symptoms in the amplicon plants was due to a mutation in the viral genome because inoculation of Virus resistance in the amplicon lines The absence of GUS activity in some cells of the amplicon non-transformed plants with virions extracted from the PVX amplicon plants led to symptoms of PVX infection plants could reflect the suppression of either transcription from the transgene or the accumulation of viral RNAs. within 7 days post inoculation. The yield of virions from the amplicon plants was 50-75% lower than from nonTo test for the latter possibility we inoculated amplicon lines with various strains of PVX. We assumed that a transformed plants that were manually inoculated with PVX (at 12 days post inoculation). Nevertheless, the mechanism able to suppress accumulation of the transgenederived viral RNA would also suppress an inoculated presence of virions in the amplicon plants indicated that the transgene-derived RNA had been replicated and that PVX and the plants would be resistant to PVX. Resistance to virus infection in the amplicon lines was subgenomic RNAs had been produced.
Expression of GUS from the amplicon constructs also assessed first by monitoring the development of symptoms after manual inoculation of different strains of PVX. The suggested that there was replication of the transgenederived RNA and production of subgenomic RNAs. There amplicon plants and controls (PVX/ΔREP/GUS and nontransformed plants) were inoculated with the PVX UK3 , was GUS activity in every plant expressing the PVX/GUS transgene but not in any of the PVX/ΔREP/GUS plants PVX NL1 , PVX CP2 , PVX NL4 and PVX CP4 isolates of PVX. The PVX UK3 isolate was the original source of the viral which expressed viral RNA unable to initiate the PVX replication cycle (Table I ). The levels of GUS in the PVX/ transgenes. The other isolates differed from PVX UK3 by up to 20% at the nucleotide sequence level (Skryabin GUS plants were similar to those in the 35S/GUS control plants (Table I) and not higher, as would be expected Huisman et al., 1989; Orman et al., 1990; Kavanagh et al., 1992; W.De Jong, unpublished) . every cell was supporting high level replication of the transgene-derived RNA (Figure 1 ). Also unexpected was
In the amplicon T 1 plants inoculated with PVX UK3 the symptoms of viral infection developed in 25% of the the degree of variation in the levels of GUS activity, between and within lines, which was as great in the PVX/ plants at the same time as in the plants expressing the PVX/ΔREP/GUS transgene or in the non-transformed GUS lines as in the 35S/GUS lines (Table I ). In plants expressing the PVX/GUS/CP transgene the levels of GUS plants. The remaining 75% of the amplicon plants failed to develop symptoms by 14 days post inoculation whereas activity were also variable but were up to one hundredfold lower than in the PVX/GUS plants ( Table I) .
all of the control plants showed symptoms within 9 days post inoculation ( Figure 4A ). This 3:1 segregation ratio In the PVX/GUS and PVX/GUS/CP plants the GUS activity was restricted to single cells or small groups of of the resistance trait indicated that resistance was expressed in most, if not all, of the transformed progeny cells. These groups of GUS-producing cells were evident in every plant expressing the PVX/GUS/CP or PVX/GUS of the amplicon lines. In contrast, symptoms developed Table I and from five lines expressing the PVX transgene were manually inoculated with 0.5 μg of virion RNA. Table I . In general, low-expressing plants showed fewer spots of GUS line: non-transformed and PVX/ΔREP/GUS plants; dashed line: activity compared to the high-expressing plants. The intensity of amplicon plants expressing CP [PVX and PVX/GUS/CP (data staining was comparable between PVX/GUS and PVX/GUS/CP plants pooled)]; stippled line: amplicon plants expressing PVX/GUS, i.e. no despite the difference in the levels of GUS activity measured by MUG CP present. Every plant showed symptoms of infection by 10 days analyses (Table I) . Plants expressing the 35S/GUS transgene showed post inoculation. A delay in the appearance of symptoms was observed uniform staining for GUS activity (data not shown). (E) Leaf from a with plants expressing a virus with CP. 6-week-old transgenic PVX/GUS plant (line SA93002). Bar represents 1 cm. (F) Boxed region in (E), bar represents 0.5 cm.
strain-specific resistance, displayed by all of the amplicon lines, was dependent on replication of the transgenederived RNA since it was not produced in the PVX/ on every amplicon and control plant inoculated with PVX CP2 , PVX CP4 , PVX NL1 and PVX NL4 , although there ΔREP/GUS plants. The weaker, broad spectrum resistance was associated with coat protein production and is probably was a slight delay in the appearance of symptoms on the plants expressing the PVX or PVX/GUS/CP transgene related to coat protein-mediated resistance conferred by 'conventional' coat protein transgenes (Hemenway compared to the PVX/GUS and control plants ( Figure  4B ). The data shown in Figure 4 are combined from et al., 1988; C.Spillane, J.Verchot, T.Kavanagh and D. Baulcombe, submitted) . This weak resistance in the several independent experiments and are particularly notable because every line generated with the PVX, PVX/ amplicon plants compared with conventional coat proteinmediated resistance may indicate that the coat protein GUS or PVX/GUS/CP construct showed resistance to PVX UK3 .
in virions confers resistance less effectively than free coat protein. From these data we conclude that the amplicon plants displayed two distinct types of resistance. There was a
To further analyse the strain-specific resistance, a PVX.GUS construct was inoculated to non-transformed strain-specific resistance and a weaker resistance effective against a broader spectrum of PVX isolates manifested as control plants and to the PVX/ΔREP/GUS and PVX plants. PVX.GUS is a PVX UK3 vector expressing the GUS reporter a slight delay in symptom expression (Figure 4 ). The gene , which produced large GUSpositive foci of infection on the non-transformed plants and the PVX/ΔREP/GUS plants ( Figure 5A ). In contrast, on the PVX plants there were no PVX.GUS foci ( Figure  5B ). Infrequently, and after prolonged histochemical staining, there were three to six small spots of GUS activity visible on the leaves of PVX plants inoculated with PVX.GUS ( Figure 5C ). Based on these reporter gene data we concluded that the absence of symptoms following inoculation of the amplicon plants with PVX UK3 was due to resistance to initial infection rather than tolerance of PVX. This conclusion was supported by the absence of detectable green fluorescence on the leaves of PVX, PVX/ GUS or PVX/GUS/CP plants inoculated with a PVX UK3 vector carrying the green fluorescent protein reporter gene (data not shown).
The conclusion that there was PVX resistance in the initially inoculated cell was confirmed by inoculation of PVX to protoplasts prepared from the transgenic plants. The inocula for these protoplast assays were in vitro synthesized transcripts of the full-length cDNA clone of PVX UK3 (Kavanagh et al., 1992) or PVX CP2 (S.SantaCruz, unpublished). RNA gel blot analysis of the protoplast extracts at 1 day post inoculation revealed that the genomic and subgenomic RNAs of both strains accumulated at high levels in the protoplasts of the non-transformed (Figure 6 ) or the PVX/ΔREP/GUS lines (data not shown). The PVX CP2 RNA accumulated to the same extent in protoplasts of the amplicon and non-transformed lines (Figure 6 ). In contrast, the protoplasts of the amplicon lines displayed extreme resistance to PVX UK3 (Figure 6 ). There was a low level of PVX RNA in the protoplasts expressing the PVX or PVX/GUS/CP transgene ( Figure  6 ). This RNA was present at the same level in both the mock-and the transcript-inoculated samples, suggesting that it was transgene-derived RNA that had become encapsidated. No transgene-derived RNA was detected in the protoplasts expressing the PVX/GUS transgene ( Figure 6 ).
The strain-specific resistance against PVX indicates the presence of an activity in the amplicon lines that inhibits accumulation of the transgene-derived RNAs by suppression of virus accumulation. This activity could account for the low and variable pattern of amplicon-mediated GUS production in addition to the strain-specific resistance to PVX. In many respects this activity is similar to homology-dependent resistance which is an RNA-mediated mechanism associated with post-transcriptional gene silencing in transgenic plants (Mueller et al., 1995; Smith et al., 1995; Swaney et al., 1995; Goodwin et al., 1996; Pang et al., 1996) . the GUS reporter construct was modified to include part or antisense orientation of the fragments in the BamHI site. The SA93002(PVX/GUS) and SA94036 (PVX/GUS/CP)]. RNA was numbers adjacent to each bar denote the resulting plasmid clone. The extracted from 50 000 protoplasts 24 h post inoculation and sizes of the PVX fragments cloned were as follows: 436, 1.7 kb; electrophoresed on a 1% (w/v) agarose-formaldehyde gel, blotted onto 438, 2.0 kb; 437, 1.0 kb; 439, 0.7 kb; 441, 0.5 kb. The PVX nylon membrane, and hybridized to an RNA probe specific for the 3Ј fragments used to produce constructs 437, 438, 439 and 441 had the end of PVX UK3 (U), or PVX CP2 (C). The autoradiographs were same 3Ј terminus, mapping to nucleotide position 6391 in the PVX exposed for 1 h. The arrows indicate the position of the genomic and genome. subgenomic RNAs.
of the PVX sequence on the 3Ј side of the GUS ORF. If mechanism was active in the PVX amplicon plants. Unfortunately, we could not perform similar analyses on gene silencing was active, we predicted that it would also suppress the accumulation of the transiently expressed the PVX/GUS or PVX/GUS/CP plants because it was not possible to distinguish between the transgene-derived GUS GUS mRNA because of the homology with the amplicon transgene. The constructs used in the transient assay were and the transiently expressed GUS. based on a plasmid expressing GUS RNA directly from the 35S promoter (pSLJ4D4; Figure 7) . Parts of the Discussion PVX UK3 cDNA clone were inserted on the 3Ј side of the GUS ORF in pSLJ4D4, in both sense and antisense
We had expected that the phenotype of the plants expressing the amplicon constructs would be influenced orientations (Figure 7 ). Each plasmid construct was coated onto gold particles and electrostatically bombarded into by virus replication. Thus, in the lines with the PVX and the PVX/GUS/CP constructs we predicted that there would the leaves of PVX, PVX/ΔREP/GUS, or non-transformed plants. Histochemical staining for GUS activity of the be virus particles and the mild mosaic symptoms of PVX infection, as in infected plants. In plants with the PVX/ bombarded leaves revealed that there was substantial and statistically significant suppression of GUS expression in GUS and the PVX/GUS/CP amplicons we had expected that there would be GUS accumulation and that the spatial the leaves of the PVX amplicon plants, but only when the plasmid constructs contained a region of the PVX genome distribution of GUS would be uniform. We had also expected that the replication of the transgene-derived PVX (Figure 8 ). Suppression was manifested as a reduced number of blue spots on the PVX amplicon leaves com-RNA would be immune to the chromosomal factors that account for the between-line variation in transgene pared with the number on the non-transformed control plants (Figure 8 ). Based on the number of blue spots in expression. In fact, the phenotype of the amplicon plants differed from these expectations in several respects. First, this transient assay, the GUS expression in the PVX plants was 50-90% less than that observed in the non-transformed virions formed in the PVX and PVX/GUS/CP plants but their accumulation was at much lower levels than in plants. Expression of GUS was suppressed from plasmids with the PVX sequences transcribed in either the sense or infected plants. Secondly, none of the amplicon plants showed symptoms of virus infection. Thirdly, there was the antisense orientation. No suppression of GUS expression in the transient assay was observed in the plants GUS activity in the PVX/GUS and PVX/GUS/CP plants, but the levels varied considerably between plants (Table I ) expressing the PVX/ΔREP/GUS transgene (Figure 8) .
The control construct, pSLJ4D4 (GUS RNA expressed and the activity was distributed non-uniformly (Figure 3) . The initial analyses of the amplicon plants indicated from the 35S promoter; Figure 7) , produced a similar number of spots on the PVX, PVX/ΔREP/GUS and nonthat these unexpected phenotypes could be accounted for by a virus resistance mechanism that is similar to the transformed plants (Figure 8) . Thus, these transient assay data indicated that a post-transcriptional gene silencing homology-dependent resistance mechanism observed in derived RNA (Figure 6 ). Homology-dependent resistance in transgenic plants is related to post-transcriptional gene silencing (Mueller et al., 1995; Smith et al., 1995; Swaney et al., 1995; Goodwin et al., 1996; Pang et al., 1996) . Because of this, we considered it likely that gene silencing would be active in the amplicon plants and that there would be suppression of nuclear genes as well as viral genes. The outcome of the transient assay for posttranscriptional gene silencing (Figure 8 ) was completely consistent with this prediction and, in the main part of this discussion, we compare the amplicon phenotype to other examples of post-transcriptional gene silencing in transgenic plants. However, before this broader assessment of post-transcriptional gene silencing we consider some notable features of the amplicon phenotype. The first of these features concerns the spotted pattern of GUS expression in the amplicon plants (Figure 3 ). Our interpretation of this phenotype is based on the assumption that the transgenically expressed viral RNA, being produced incessantly in most cells, would provide an intense pressure for infection. From time to time this intense infection pressure would overcome the resistance to give virus accumulation and, with PVX/GUS and PVX/GUS/ CP plants, lead to transient expression of the GUS gene carried in the amplicon construct. An alternative explanation in which the GUS spots are attributed to somatic instability of the resistance mechanism is less likely because the pattern of GUS expression did not correspond to developmental sectors in the leaves. Moreover, no PVX-susceptible leaf sectors were observed after manual inoculation of PVX.GUS to the amplicon plants ( Figure 5) .
A second notable feature of the amplicon phenotypes is the 100-fold difference in the level of GUS in the PVX/ GUS and PVX/GUS/CP lines. In principle this difference could have been due to substantially more effective gene silencing in the PVX/GUS/CP lines in which the GUS (Table I) a negative regulator of subgenomic RNA production discs. Each experiment contained six to eight control leaf discs excised . According to this idea, the from non-transformed plants (black bar). Experimental data were PVX coat protein in the PVX/GUS/CP lines would have standardized such that the mean for the control discs in each suppressed production of the GUS mRNA from the experiment was 100. For each construct, the data have been pooled [for each construct we used plant lines SA93039 and SA94057 (PVX/ amplicon construct and thereby suppressed GUS synthesis. be more active . occurs at a low frequency (Matzke et al., 1989; Hart et al., 1992) . In contrast, gene silencing, as indicated by virus resistance and the transient assay, was activated in every plants expressing part of a viral genome (Mueller et al., 1995; Smith et al., 1995; Swaney et al., 1995; Dawson, one of 17 amplicon lines tested. We conclude from this consistency of the amplicon phenotype and its absence in 1996; Goodwin et al., 1996; Pang et al., 1996) . This homology-dependent resistance, like the resistance in the the PVX/ΔREP/GUS lines that a replicating PVX genome is a potent activator of gene silencing in the amplicon amplicon plants, is both highly strain specific (Figures 4, 5 and 6) and associated with low accumulation of transgeneplants.
Although there are other reports describing transgenic a usual response to virus infection of non-transformed plants. Therefore, activation of gene silencing requires expression of plant viral genomes, the phenotypes of these more than just high level accumulation of an RNA species. plants did not clearly indicate that gene silencing was A second factor that may be involved in virus-induced activated. For example, as with the amplicon plants, there gene silencing is sequence homology of the virus with was virus resistance in plants expressing a mild strain of either a transgene or an endogenous gene. As a result of tobacco mosaic virus (TMV) (Yamaya et al., 1988b) .
this homology there could be an interaction of the viral However, this resistance was not observed in plants genome with the nuclear DNA. A precedent for an RNAexpressing a virulent strain of TMV (Yamaya et al., 1988a) .
DNA interaction that could be relevant to virus-induced In plants expressing cucumber mosaic virus (CMV) RNAs gene silencing is in transgenic tobacco plants expressing 1 and 2 there was resistance to challenge inoculation with viroid cDNAs. The presence of replicating viroid RNA in CMV. This resistance was more effective against RNA these plants caused sequence-specific methylation of the rather than virion inocula (Suzuki et al., 1996) . However, viroid transgene (Wassenegger et al., 1994) . If there is unlike the amplicon plants, the CMV resistance was RNA-directed DNA methylation in the plants displaying not strain-specific and was associated with a high level virus-induced gene silencing it could initiate a sequence accumulation of the transgene-derived RNA (Suzuki et al., of events leading to post-transcriptional gene silencing. In 1996). In a further example, Nicotiana tabacum plants several examples of gene silencing induced by convenwere transformed with replicating RNAs 1 and 2 of brome tional transgenes it has been suggested that DNA methylmosaic virus (BMV). Protoplasts from these plants were ation could be implicated (Hobbs et al., 1990 (Hobbs et al., , 1993 ; resistant to BMV but not to CMV, and showed a low Ingelbrecht et al., 1994; Smith et al., 1994; English et al. , level accumulation of the transgene-derived RNAs (Kaido 1996) . However, as for the RNA threshold, this proposed et al., 1995) . Also, transgenic plants expressing BMV RNA-DNA interaction leading to DNA methylation canRNAs carrying the human gamma interferon (IFN-γ) gene not be a single factor that is sufficient for activation of failed to accumulate the predicted high levels of IFN-γ gene silencing. Our PVX/ΔREP/GUS plants and all other (Mori et al., 1993) . In the light of the data presented here, transgenic plants that do not display gene silencing illusin particular those from the transient expression assay, it trate that homology of an RNA with a transgene will not seems likely that these phenotypes of the BMV transgenic necessarily lead to gene silencing. plants can be explained by gene silencing.
A third factor that has been invoked as an initiator of post-transcriptional gene silencing in transgenic plants is Consistent with this proposed activation of gene silencthe presence of aberrant RNA. 'Aberrancy' in this scenario ing by the transgenic expression of replicable viral is a feature of the RNA that somehow differs from RNAs genomes, there are reports of other virus-mediated effects that are encountered by cells in situations that do not lead that may also be due to gene silencing. These include the to gene silencing. The gene silencing in the amplicon photobleaching symptoms induced by modified TMV plants could fit into this aberrant RNA model if the viral vectors carrying part of a phytoene desaturase gene that RNA transcribed from the transgene represents a modified were inoculated to Nicotiana benthamiana (Kumagai et al., (i.e. aberrant RNA) template for the viral replicase. Altern-1995) . The viral vector induced suppression of the host atively the aberrancy could be concerned with the site or phytoene desaturase gene in the infected tissue which timing of viral RNA synthesis rather than a structural consequently lacked carotenoid protection and became feature. photobleached (Kumagai et al., 1995) . In a second Our current work is directed towards understanding the example, transgenes based on the coat protein ORF of mechanism of virus-induced gene silencing in infected potyviruses became silenced following infection of the and transgenic plants. Meanwhile, even without undertransgenic plants with the corresponding potyvirus (Lindbo standing the underlying mechanism, the analyses presented et Dougherty et al., 1994; Smith et al., 1994) .
here suggest that amplicon constructs may represent a Associated with this silencing of the transgene there was more reproducible approach for the activation of gene also virus resistance operating at the RNA level which silencing in transgenic plants than is currently available. was manifested as recovery of the plant from a diseased In 17 lines tested there was remarkably little variation in to a healthy condition (Lindbo et al., 1993 ; Dougherty the level of gene silencing as indicated by the virus et al., 1994; Smith et al., 1994) .
resistance and transient expression assays (three lines Why do some inoculated or transgenically expressed tested). None of the other approaches to gene silencing, viruses activate gene silencing? It could be in part because including those involving increased transgene dosage, their RNAs accumulate at a very high level and activate high-level transgene expression or the presence of direct a sequence-specific mechanism of RNA degradation. This or inverted repeats in the transgene construct, produces threshold model has been invoked previously to account an effect that is as reproducible from line to line as the for the recovery phenomenon in transgenic plants (Lindbo amplicon-mediated gene silencing described here. Future et al., 1993; Dougherty et al., 1994; Smith et al., 1994) experiments will test the potential of the amplicon constructs to silence a range of viruses and nuclear genes in and the requirement for viral replication to activate gene plants. In addition it would be interesting to find out silencing in our plants is consistent with this. However, whether gene silencing in organisms other than plants can we do not consider that a high level of an RNA species be activated by replicable viral RNAs. is sufficient to activate gene silencing and the associated homology-dependent resistance. If a high level accumula-
Materials and methods
tion of an RNA was all that was needed, the accumulation of an inoculated virus should lead to recovery as in the Constructs and plant transformation plants with potyvirus transgenes, even in non-transformed All of the viral cDNA constructs were inserted between the CaMV 35S promoter and the transcriptional terminator of the nopaline synthase plants. Common observation reveals that recovery is not (nos) gene and transferred into the binary vector pSLJ7291. PVX was and Paul Christou for allowing us the use of the ACCELL gene delivery machine. We are grateful to the Gatsby Charitable Foundation for the full-length cDNA clone of PVX (Figure 2 ). PVX/GUS was the PVX cDNA clone carrying the GUS gene as a direct replacement for the coat continuing support and the BBSRC for grant PG83/557. protein gene (Figure 2 ). PVX/ΔREP/GUS was generated by digestion of PVX/GUS with BglII restriction enzyme and religation (Figure 2 ).
